Among patients with nonischemic cardiomyopathy who require cardiac resynchronization therapy, a pacemaker may have comparable efficacy and more cost efficiency compared with a defibrillator, according ...

Dallas, TX - The largest-yet analysis of its kind supports the use of cardiac resynchronization therapy (CRT), either with or without defibrillator backup, in patients with NYHA class 4 heart failure, ...

Orlando, FL - In a post-hoc analysis of the COMPANION trial, one of the foundations for use of cardiac resynchronization therapy (CRT) in patients with heart failure, the device therapy known for ...

Barcelona, Spain, 1 September: The European cardiac resynchronization therapy (CRT) Survey is a joint initiative taken by the Heart Failure Association (HFA) and European Heart Rhythm Association ...